Jessica Tarnow Wilan
Plus aucun poste en cours
Provenance du réseau au premier degré de Jessica Tarnow Wilan
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jessica Tarnow Wilan via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Chairman | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| KADMON HOLDINGS, INC. | Biotechnology | Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member | |
SVB Capital
 SVB Capital Investment ManagersFinance SVB Capital Management LLC (SVB Capital Management) is a venture capital arm of SVB Financial Group founded in 2000 by Aaron Gershenberg and Gregory Becker. The firm is headquartered in Santa Clara, California. | Investment Managers | Private Equity Investor | |
| Ithaca College | College/University | Undergraduate Degree | |
| Murray State University (Kentucky) | College/University | Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MESOBLAST LIMITED | Biotechnology | Director/Board Member | |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments. | Investment Banks/Brokers | Corporate Officer/Principal | |
| DIPLOMAT PHARMACY, INC. | Drugstore Chains | Director/Board Member | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
| University of California | College/University | Undergraduate Degree | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Johnson & Johnson Innovation LLC
 Johnson & Johnson Innovation LLC Medical/Nursing ServicesHealth Services Part of Johnson & Johnson, Johnson & Johnson Innovation LLC focuses on accelerating innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's healthcare businesses. The private company is based in South San Francisco, CA. Johnson & Johnson Innovation provides scientists, entrepreneurs, and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device, and consumer companies of Johnson & Johnson. The company connects with innovators through its regional innovation centers, Johnson & Johnson Innovation - JLABS, JJDC, Inc., and its business development teams to create customized deals and novel collaborations that speed up the development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools, and resources needed to help life science startups thrive, all with no strings attached. Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. | Medical/Nursing Services | Director/Board Member | |
dRx Capital AG
 dRx Capital AG Investment ManagersFinance dRx Capital AG (dRx Capital) is a investment arm of Novartis AG founded in 2015 by Valencia Rick. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Strata Oncology, Inc.
 Strata Oncology, Inc. Pharmaceuticals: MajorHealth Technology Strata Oncology, Inc. manufactures oncology drugs. It provides comprehensive testing, portfolio of treatments, peace of mind. The company was founded by Daniel D. Rhodes, Scott Tomlin and Keith T. Flaherty in 2015 and is headquartered Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Shawn Tomasello Consulting LLC
 Shawn Tomasello Consulting LLC Miscellaneous Commercial ServicesCommercial Services Shawn Tomasello Consulting LLC provides business consulting services. The private company is based in Miramar Beach. The American company was founded by Shawn Cline Tomasello. | Miscellaneous Commercial Services | Chief Executive Officer | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Biotechnology | Director/Board Member | |
| CABALETTA BIO, INC. | Biotechnology | Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | Director/Board Member | |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
| VAXART, INC. | Biotechnology | Director of Finance/CFO | |
| CLOVER BIOPHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
TEN63 Therapeutics
 TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Altum Pharmaceuticals, Inc.
 Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Pharmaceuticals: Generic | Chairman |
Statistiques
Internationale
| Etats-Unis | 43 |
| Canada | 3 |
| Royaume-Uni | 2 |
| Irlande | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 36 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Finance | 4 |
| Retail Trade | 2 |
Opérationnelle
| Director/Board Member | 57 |
| Corporate Officer/Principal | 24 |
| Independent Dir/Board Member | 24 |
| Undergraduate Degree | 8 |
| Chief Tech/Sci/R&D Officer | 8 |
Relations les plus connectées
| Insiders | |
|---|---|
| Shawn Tomasello | 22 |
| Susannah Gray | 20 |
| Bill Burkoth | 19 |
| Nancy Miller-Rich | 15 |
| Robert Fishman | 11 |
| John Milligan | 9 |
| Phillip Eric Lee | 7 |
| Carolyne Zimmermann | 7 |
- Bourse
- Insiders
- Jessica Tarnow Wilan
- Connexions Sociétés
